Search
for

    Sort by

    Research 391–420 of 541

    1. Male pattern baldness and the risk of prostate cancer Annals of Oncology · 2011 · 38 citations
    2. Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink BMJ · 2016 · 30 citations
    3. Specialization and the Physician Workforce JAMA · 2000 · 27 citations
    4. Post-finasteride syndrome: An emerging clinical problem Neurobiology of Stress · 2019 · 26 citations
    5. Morphometric-stereological and functional epididymal alterations and a decrease in fertility in rats treated with finasteride and after a 30-day post-treatment recovery period Fertility and Sterility · 2012 · 20 citations
    6. Preventive effects of cedrol against alopecia in cyclophosphamide-treated mice Environmental Toxicology and Pharmacology · 2016 · 14 citations
    7. Antiandrogen therapy for androgenetic alopecia Expert Review of Dermatology · 2006 · 14 citations
    8. Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction. PubMed · 2012 · 13 citations
    9. Nocebo effect in Dermatology Indian Journal of Dermatology, Venereology and Leprology · 2015 · 12 citations
    10. Cystine-thiamin-containing hair-growth formulation modulates the response to UV radiation in an in vitro model for growth-limiting conditions of human keratinocytes Journal of Photochemistry and Photobiology B-biology · 2018 · 9 citations
    11. THERAPEUTIC HOTLINE: Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction? Dermatologic Therapy · 2010 · 9 citations
    12. Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries Cancer Medicine · 2017 · 8 citations
    13. Parathyroid hormone linked to a collagen binding domain promotes hair growth in a mouse model of chemotherapy-induced alopecia in a dose-dependent manner Anti-Cancer Drugs · 2014 · 8 citations
    14. The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma Current Dermatology Reports · 2013 · 6 citations
    15. Malignant epithelial tumors: Part II. Therapy and prevention Journal der Deutschen Dermatologischen Gesellschaft · 2013 · 5 citations
    16. Hair, Hormones, and High-Risk Prostate Cancer Journal of Clinical Oncology · 2014 · 3 citations
    17. RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER 2005 · 3 citations
    18. Evaluation of COVID-19 risk in patients on systemic retinoid therapy TURKDERM · 2022 · 1 citations
    19. Cost-effectively dissecting the genetic architecture of complex wool traits in rabbits by low-coverage sequencing bioRxiv (Cold Spring Harbor Laboratory) · 2022 · 1 citations
    20. Re: Can Long-Term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention? The Journal of Urology · 2017 · 1 citations
    21. Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment Frontiers in Drug Discovery · 2026
    22. ラット精巣におけるビタミンD 代謝関連遺伝子の発現解析 Institutional Repositories DataBase (IRDB) · 2025
    23. Salivary Gland Inflammation During Acitretin Therapy for Generalized Pustular Psoriasis: a Case Report and Diagnostic Challenge Dermatology Review · 2025
    24. Rothmund Thomson syndrome with late onset and good preventive control of non-melanoma cancer with acitretin: case report Journal of Dermatology & Cosmetology · 2024
    25. Actinic Keratosis: Risk Factors, Clinical, Diagnosis and Therapeutics Aspects. Part I Dermatovenerologiâ, kosmetologiâ · 2024
    26. Androgen deprivation therapy and hormonal status in men with COVID-19 Urology Herald · 2022
    27. Re: Long-Term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial The Journal of Urology · 2017
    28. Hair loss at 20 associated with prostate cancer risk later in life Cancer · 2011
    29. News in brief Expert Review of Endocrinology & Metabolism · 2011
    30. Finasteride en el año 2006 Revista Argentina de Urología · 2006